Elisheva Stav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisheva Stav has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adi Rotem
Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication - Alon Gutfreund
The Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication - Hagai Rappeport
The Hebrew University of Jerusalem
1 shared publication - Irine Ronin
Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
1 shared publication - Nathalie Q. Balaban
Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication Nitsan Naor
Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eadt6577
Differentiation between regulated and disrupted growth arrests allows tailoring of effective treatments for antibiotic persistence
Antibiotic persistence, typically attributed to dormant bacteria, is known to be a major cause of treatment failure. However, despite many years of intense research, no clear consensus on its mechanism has emerged. Here, we demonstrate that high survival under antibiotics may originate from two fundamentally different growth-arrest archetypes: either from a regulated growth arrest, leading to a protected dormant cellular state, or from a dysregulated disrupted growth arrest. Using modeling and experimental approaches including transcriptomics, microcalorimetry, and microfluidics, we unveil the characteristics and vulnerabilities of each growth-arrest archetype. In particular, disrupted bacteria show a general impairment of membrane homeostasis. This understanding resolves previous conflicting results regarding characteristics of persisters and allows tailoring treatments that target the different growth-arrested bacteria. The fundamental distinction between regulated and disrupted growth arrests should be broadly relevant for the description of cells under stress.
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eadt6577
Top Cited PapersOpen AccessDifferentiation between regulated and disrupted growth arrests allows tailoring of effective treatments for antibiotic persistence
Antibiotic persistence, typically attributed to dormant bacteria, is known to be a major cause of treatment failure. However, despite many years of intense research, no clear consensus on its mechanism has emerged. Here, we demonstrate that high survival under antibiotics may originate from two fundamentally different growth-arrest archetypes: either from a regulated growth arrest, leading to a protected dormant cellular state, or from a dysregulated disrupted growth arrest. Using modeling and experimental approaches including transcriptomics, microcalorimetry, and microfluidics, we unveil the characteristics and vulnerabilities of each growth-arrest archetype. In particular, disrupted bacteria show a general impairment of membrane homeostasis. This understanding resolves previous conflicting results regarding characteristics of persisters and allows tailoring treatments that target the different growth-arrested bacteria. The fundamental distinction between regulated and disrupted growth arrests should be broadly relevant for the description of cells under stress.